Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
about
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressorComprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo.Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.Potential of soluble CD26 as a serum marker for colorectal cancer detection.Oncogenes in melanomas.Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial functionTransformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression.A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)Dipeptidyl peptidase-IV and related molecules: markers of malignancy?DPPIV/CD26: a tumor suppressor or a marker of malignancy?Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice.Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi.Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
P2860
Q28513202-802A41F3-55DD-41CE-8374-2376CE71537CQ33289965-2BD6CC17-701D-4A9D-8F54-849DFD386A3DQ34386621-2E1009C2-8B2B-4DD2-A8EE-D4DB84726D51Q35102870-86386B6D-0517-4C67-ABA9-B0E4D4B0F355Q35113393-FD8E3FC3-0B8F-4A5B-869A-89DAA124C333Q35204292-21F10C7A-C937-4252-B004-1D42FE84B001Q36098601-F36CF849-1275-496A-9D3C-4F389C3C8512Q36356124-8A0F8BC8-A151-4DD3-9D08-496AE5A39D03Q36361511-635E8FCF-CC86-436D-B65C-FCC9BDAAB772Q36375190-C8DE6006-8E68-4F2A-B931-A41E48F75F2CQ36736740-661EDFC6-7CDB-4EDE-854B-5254021219E1Q38089765-8643E40A-DA7B-4E50-9E2E-80605FA8A629Q38760903-0D587624-5CC0-4C3A-90BE-C70CE0DFA216Q38953667-1A17BDCE-4A09-477A-99CA-D05EE65D7F25Q38987177-2F91C483-4CD3-4185-B7A5-5617693FFC0CQ39210448-DFF49015-5C62-4E21-9003-FE0AE10C0EDAQ40308628-F53BCE3B-C84A-4E09-B8E3-4A29A5D751B1Q40579325-FEF05202-C99C-4C86-91BC-906335DE0A80Q42065004-0EE05E40-7CDF-4D46-8CD3-74BA7E225195
P2860
Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Cell surface antigens of human ...... ith melanocyte transformation.
@ast
Cell surface antigens of human ...... ith melanocyte transformation.
@en
type
label
Cell surface antigens of human ...... ith melanocyte transformation.
@ast
Cell surface antigens of human ...... ith melanocyte transformation.
@en
prefLabel
Cell surface antigens of human ...... ith melanocyte transformation.
@ast
Cell surface antigens of human ...... ith melanocyte transformation.
@en
P2093
P2860
P356
P1476
Cell surface antigens of human ...... ith melanocyte transformation.
@en
P2093
A N Houghton
A P Albino
C Cordon-Cardo
M Eisinger
P2860
P304
P356
10.1084/JEM.167.1.197
P407
P577
1988-01-01T00:00:00Z